Strategic Partners A/S

F:1TB0 Germany Biotechnology
Market Cap
$3.23 Million
€3.14 Million EUR
Market Cap Rank
#35426 Global
#4182 in Germany
Share Price
€76.00
Change (1 day)
+0.00%
52-Week Range
€74.60 - €96.00
All Time High
€96.00
About

Strategic Partners A/S does not have significant operations. Previously, it was engaged in biotech activities. The company was formerly known as Orphazyme A/S and changed its name to Strategic Partners A/S in October 2024. The company was founded in 2009 and is based in Herlev, Denmark.

Strategic Partners A/S - Asset Resilience Ratio

Latest as of June 2025: 63.94%

Strategic Partners A/S (1TB0) has an Asset Resilience Ratio of 63.94% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets
€12.05 Million
Cash + Short-term Investments
Total Assets
€18.85 Million
All company assets
Resilience Assessment
Very High
Financial Resilience Level

Asset Resilience Ratio Trend (2023–2024)

This chart shows how Strategic Partners A/S's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.

Liquid Assets Composition Over Time

This chart breaks down Strategic Partners A/S's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents €0.00 0%
Short-term Investments €12.05 Million 63.94%
Total Liquid Assets €12.05 Million 63.94%

Asset Resilience Insights

  • Very High Liquidity: Strategic Partners A/S maintains exceptional liquid asset reserves at 63.94% of total assets.
  • This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
  • The company has significant short-term investments, indicating active treasury management.

Strategic Partners A/S Industry Peers by Asset Resilience Ratio

Compare Strategic Partners A/S's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
MedPacto Inc
KQ:235980
Biotechnology 49.82%
Shenzhen CAU Technology Co Ltd
SHE:000004
Biotechnology 6.20%
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403
Biotechnology 6.88%
Nanhua Bio Medicine Co Ltd
SHE:000504
Biotechnology 11.93%
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518
Biotechnology 0.03%
Chengzhi Shareholding Co Ltd
SHE:000990
Biotechnology 6.73%
Hualan Biological EngineeringInc
SHE:002007
Biotechnology 14.68%
Da An Gene Co Ltd of Sun Yat-Sen University
SHE:002030
Biotechnology 4.35%

Annual Asset Resilience Ratio for Strategic Partners A/S (2023–2024)

The table below shows the annual Asset Resilience Ratio data for Strategic Partners A/S.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-12-31 68.28% €16.09 Million €23.56 Million +32.33pp
2023-12-31 35.96% €6.94 Million €19.31 Million --
pp = percentage points